| Characteristics | CKD+ (N = 26) | CKD− (N = 208) | OR IC 95% | P | ||
| N | (%) | N | (%) | |||
| Sexe |
|
|
|
| 1.21 [0.90; 3.60] | 0.339 |
| Male | 4 | 15.38 | 66 | 31.73 |
|
|
| Female | 22 | 84.62 | 142 | 68.27 |
|
|
| Age (years) |
|
|
|
| 4.17 [1.09; 20.34] | 0.017 |
| ≤45 | 43 | 15.38 | 104 | 50.00 |
|
|
| >45 | 22 | 84.62 | 104 | 50.00 |
|
|
| HBP |
|
|
|
| 2.81 [0.98; 8.04] | 0.078 |
| Yes | 8 | 30.77 | 24 | 11.54 |
|
|
| No | 18 | 69.23 | 184 | 88.46 |
|
|
| Diabetes |
|
|
|
| 4.79 [1.08; 21.17] | 0.21 |
| Yes | 2 | 7.69 | 2 | 0.96 |
|
|
| No | 24 | 92.31 | 206 | 99.04 |
|
|
| BMI (kg/m2) |
|
|
|
| 0.82 [0.27; 2.51] | 0.49 |
| <25 | 8 | 30.77 | 74 | 35.58 |
|
|
| ≥25 | 18 | 69.23 | 134 | 64.42 |
|
|
| WHO Clinical Stage |
|
|
|
| - | 0.857 |
| Stage 1 | 6 | 23.08 | 42 | 20.20 |
|
|
| Stage 2 | 10 | 38.46 | 62 | 29.82 |
|
|
| Stage 3 | 8 | 30.77 | 68 | 32.69 |
|
|
| Stage 4 | 2 | 7.69 | 36 | 17.29 |
|
|
| Pathological proteinuria |
|
|
|
| 3.38 [1.23; 9.27] | 0.021 |
| Yes | 14 | 53.85 | 46 | 22.12 |
|
|
| No | 12 | 46.15 | 162 | 77.88 |
|
|
| CD4 rate |
|
|
|
| 8.58 [0.31; 4.51] | 0.51 |
| <200 | 14 | 53.85 | 104 | 50 |
|
|
| ≥200 | 12 | 46.15 | 104 | 50 |
|
|